RA101495
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RA101495, covering 2022-06-27 to 2022-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical Study [Phase 2]